The report will be delivered in 2-3 business days.

COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change

Starting Price : $ 4000.00 | Pages : 150 | Published : July 2020 | SKU CODE : 7645 | Format :


The COVID19 drug-associated APIs market consists of sales of active pharmaceutical ingredients used in the manufacturing of COVID19 drugs. The active pharmaceutical ingredients are chemicals which are responsible for pharmacological activity in the human body and are used as a base in pharmaceutical drug or medicine. The APIs used for the preparation of COVID19 drugs and include Azithromycin, Fentanyl, Albuterol, Cisatracurium and others.

The global COVID-19 associated API market is expected to grow from $4.07 billion in 2019 to $5.11 billion by the end of 2020 at a compound annual growth rate (CAGR) of 25.6%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. However, with the COVID-19 cases continuously increasing, restrictive containment measures involving social distancing are enforcing the closure of industries and other commercial activities. This has an impact on all stages from production to international trade attributing to transportation and supply chain disruptions. The market is expected to reach $6.02 billion in 2023 at a CAGR of 5.6%.

Asia Pacific is anticipated to be the largest region in the COVID-19 associated API market by the end of 2020.

The COVID19 drug-associated APIs market covered in this report is segmented by drug class into antimalarials, bronchodilators, antibiotics, antivirals, others.

High demand for some antiretrovirals, antimalarials, sedatives, bronchodilators, and other respiratory drugs drives the demand for the active pharmaceutical ingredients (APIs) used in the production of COVID19 drugs. Active pharmaceutical ingredients (APIs) are the biologically active component used in manufacturing pharmaceutical drugs. Remdesivir and Favipiravir are two common antiviral medications used currently for the treatment of COVID19 patients. Remdesivir is a medication approved for emergency use in the USA and Japan for the treatment of COVID19 patients. Remdesivir gained emergency use authorization (EUA) from the FDA on May 1, 2020, based on its preliminary data showing a faster time to recovery in hospitalized patients with several diseases. Favipiravir, which used to treat influenza in Japan, has also shown a positive effect on COVID patients. As COVID-19 is a respiratory ailment, the demand for bronchodilators spiked significantly. Therefore, the increasing demand for antivirals, antimalarials, and bronchodilators is projected to boost the demand for COVID19 associated drug APIs market over the forecast period.

The disruptions caused by the COVID19 outbreak in the supply chain of medical products limited the growth of the COVID-19 drug-associated APIs market in the past few months. The source for APIs plays a crucial part in the strategic plan to combat the COVID19 pandemic. The majority of APIs for generic drug manufacturing across the globe are sourced from India, with nearly 30% generic APIs used in the USA. The restrictions imposed on the export of pharma products owing to COVID19 supply chain disruptions restricted the market growth. For instance, India imposed an export ban on 26 pharma products and medical devices in March 2020. The ban was imposed attributing to the supply chain disruptions on API and other bulk drugs due to restrictive measures such as lockdown and closure of factories in many countries across the globe to ensure that the disease spread is contained. Thus, shortages caused by the disruptions in supply chains and restrictions imposed on the export of pharma products impacted the growth of the COVID19 drug-associated APIs market over the last few months.

Key players operating in the pharmaceutical industry that manufactures COVID19 drug associated APIs are focusing on strategies such as plant capacity or production capacity expansion to meet the increasing demand due to the rising number of coronavirus cases across the globe. For instance, in March 2020, Alembic Pharmaceuticals Ltd announced that the company is ramping up the production for the company’s production for azithromycin to 20 tons per month. Likewise, In April 2020, FUJIFILM Corporation announced the expansion of its manufacturing capacity and increase in the production of influenza antiviral Avigan Tablet (Favipiravir) by nearly 2.5 times by the end of July. Avigan is currently undergoing clinical trials testing its safety and efficacy for the treatment of COVID19 patients.

In February 2020, Dr. Reddy Labs announced the acquisition of the branded generics business of Wockhardt for an amount of $242 million (INR 1,850 crore). The acquisition is expected to scale-up the former company’s presence in home markets including India, Nepal, Sri Lanka, Bhutan, and the Maldives. The Wockhardt business consists of a product portfolio of 62 brands and in multiple therapy fields such as dermatology, neurology, respiratory, VMS, pain, gastroenterology, and vaccine. Wockhardt Ltd. was founded in 1999 and is a global biotechnology and pharmaceutical company based in Mumbai, India.

The major players covered in the COVID19 Drug Associated APIs Global Market Report are Dr. Reddy`s Laboratories, Lianyungang Guike Pharmaceutical, Alembic Pharmaceutical, Wockhardt Ltd, Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical (Haimen) Co Ltd, Yatai Pharma, Zhejiang Guobang Pharmaceutical Co Ltd., Cipla, Shandong Boyuan Pharmaceutical, Aspiro Pharma, Qilu Antibiotics Pharmaceutical Co Ltd, Shenzhen China Resources Gosun Pharmaceutical Co Ltd., Zhejiang Cheng Yi Pharmaceutical, Star Lake Bioscience Co Inc., Hetero Labs, Geno Pharmaceuticals, Mylan Laboratories, IPCA Labs, Zydus Takeda, Mangalam Drugs & Organics, Wallace Pharma.

The regions covered in the global drug associated api market data report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the global drug associated api market data report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

    1. Executive Summary

    2. COVID19 Drug Associated APIs Market Characteristics

    3. COVID19 Drug Associated APIs Market Size And Growth

    3.1. Global COVID19 Drug Associated APIs Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global COVID19 Drug Associated APIs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. COVID19 Drug Associated APIs Market Segmentation

    4.1. Global COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Antimalarials

    Bronchodilators

    Antibiotics

    Antivirals

    Others

    5. COVID19 Drug Associated APIs Market Regional And Country Analysis

    5.1. Global COVID19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global COVID19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific COVID19 Drug Associated APIs Market

    6.1. Asia-Pacific COVID19 Drug Associated APIs Market Overview

    6.2. Asia-Pacific COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China COVID19 Drug Associated APIs Market

    7.1. China COVID19 Drug Associated APIs Market Overview

    7.2. China COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India COVID19 Drug Associated APIs Market

    8.1. India COVID19 Drug Associated APIs Market Overview

    8.2. India COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan COVID19 Drug Associated APIs Market

    9.1. Japan COVID19 Drug Associated APIs Market Overview

    9.2. Japan COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia COVID19 Drug Associated APIs Market

    10.1. Australia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia COVID19 Drug Associated APIs Market

    11.1. Indonesia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea COVID19 Drug Associated APIs Market

    12.1. South Korea COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe COVID19 Drug Associated APIs Market

    13.1. Western Europe COVID19 Drug Associated APIs Market Overview

    13.2. Western Europe COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK COVID19 Drug Associated APIs Market

    14.1. UK COVID19 Drug Associated APIs Market Overview

    14.2. UK COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany COVID19 Drug Associated APIs Market

    15.1. Germany COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France COVID19 Drug Associated APIs Market

    16.3. France COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe COVID19 Drug Associated APIs Market

    17.1. Eastern Europe COVID19 Drug Associated APIs Market Overview

    17.2. Eastern Europe COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia COVID19 Drug Associated APIs Market

    18.1. Russia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America COVID19 Drug Associated APIs Market

    19.1. North America COVID19 Drug Associated APIs Market Overview

    19.2. North America COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA COVID19 Drug Associated APIs Market

    20.1. USA COVID19 Drug Associated APIs Market Overview

    20.2. USA COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America COVID19 Drug Associated APIs Market

    21.1. South America COVID19 Drug Associated APIs Market Overview

    21.2. South America COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil COVID19 Drug Associated APIs Market

    22.1. Brazil COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East COVID19 Drug Associated APIs Market

    23.1. Middle East COVID19 Drug Associated APIs Market Overview

    23.2. Middle East COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa COVID19 Drug Associated APIs Market

    24.1. Africa COVID19 Drug Associated APIs Market Overview

    24.2. Africa COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. COVID19 Drug Associated APIs Market Competitive Landscape And Company Profiles

    25.1. COVID19 Drug Associated APIs Market Competitive Landscape

    25.2. COVID19 Drug Associated APIs Market Company Profiles

    25.2.1. Dr. Reddy`s Laboratories

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Lianyungang Guike Pharmaceutical

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Alembic Pharmaceutical

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Wockhardt Ltd

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Sandoz Srl

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The COVID19 Drug Associated APIs Market

    27. COVID19 Drug Associated APIs Market Trends And Strategies

    28. COVID19 Drug Associated APIs Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global COVID19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global COVID19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Asia-Pacific, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: China, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: India, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Japan, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Australia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Indonesia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: South Korea, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Western Europe, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: UK, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Germany, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: France, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Eastern Europe, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Russia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: North America, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: USA, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: South America, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Brazil, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Middle East, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Africa, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Dr. Reddy`s Laboratories Financial Performance
  • Table 26: Lianyungang Guike Pharmaceutical Financial Performance
  • Table 27: Alembic Pharmaceutical Financial Performance
  • Table 28: Wockhardt Ltd Financial Performance
  • Table 29: Sandoz Srl Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global COVID19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global COVID19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Asia-Pacific, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: China, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: India, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Japan, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Australia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Indonesia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: South Korea, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Western Europe, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: UK, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Germany, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: France, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Eastern Europe, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Russia, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: North America, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: USA, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: South America, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Brazil, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Middle East, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Africa, COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Dr. Reddy`s Laboratories Financial Performance
  • Figure 26: Lianyungang Guike Pharmaceutical Financial Performance
  • Figure 27: Alembic Pharmaceutical Financial Performance
  • Figure 28: Wockhardt Ltd Financial Performance
  • Figure 29: Sandoz Srl Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report
Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)